#$%^&*AU2011101625A420120119.pdf#####ABSTRACT A method is provided for administering to a mammal suffering from, or at risk for, an intraocular neovascular disorder with regular dosing of a therapeutically effective amount of VEGF antagonist, followed by less frequent dosing of a therapeutically 5 effective amount of VEGF antagonist. 3010660_1 (GHMatter) P71763.AU.1 9-Dec1